The effect of alkaloid from Oxytropis ochrocephala on growth inhibition and expression of PCNA and p53 in mice bearing H22 hepatocellular carcinoma

Yakugaku Zasshi

Volumn 125, Issue 8, 2005, Pages 665-670

  Long, Ling ^a   Li, Qingwang ^a,b  

^a NORTHWEST A F UNIVERSITY   (China)

^b YANSHAN UNIVERSITY   (China)

Author keywords

Alkaloid; Antitumor activity; H22 hepatocellular carcinoma; Mutant p53 protein; Oxytropis ochrocephala; PCNA

Indexed keywords

ALKALOID; CYCLINE; MUTANT PROTEIN; PROTEIN P53; ANTINEOPLASTIC AGENT;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTINEOPLASTIC ACTIVITY; ARTICLE; ATROPHY; BODY WEIGHT; CANCER INHIBITION; CELL COUNT; CELL NUCLEUS; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG ISOLATION; DRUG MECHANISM; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; LIVER TOXICITY; MALE; MOUSE; NEPHROTOXICITY; NONHUMAN; OXYTROPIS; PROTEIN EXPRESSION; TUMOR CELL; TUMOR VOLUME; ANIMAL; CANCER TRANSPLANTATION; CELL PROLIFERATION; CHEMICAL PHENOMENA; CHEMISTRY; GENE EXPRESSION REGULATION; GENETICS; ISOLATION AND PURIFICATION; LIVER TUMOR; METABOLISM; MOUSE STRAIN; MUTATION; PATHOLOGY;

ALKALOIDS; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CARCINOMA, HEPATOCELLULAR; CELL PROLIFERATION; DEPRESSION, CHEMICAL; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION, NEOPLASTIC; LIVER NEOPLASMS; MALE; MICE; MICE, INBRED STRAINS; MUTATION; NEOPLASM TRANSPLANTATION; OXYTROPIS; PROLIFERATING CELL NUCLEAR ANTIGEN; TUMOR SUPPRESSOR PROTEIN P53;

EID: 24944439967     PISSN: 00316903     EISSN: None     Source Type: Journal    
DOI: 10.1248/yakushi.125.665     Document Type: Article

References (24)

1. Cragg G. M., Boyd M. R., Cardellina J. H., Newman D. J., Snader K. M., McCloud T. G., "Ethnobotany and Search for New Drugs," the US National Cancer Institute, 1994 p. 3.
2. Chuang S. E., Kuo M. L., Hsu C. H., Chen C. R., Lin J. K., Lai G. M., Hsieh, C.Y., Cheng, A. L., Carcinogenesis, 21, 331-335 (2000).
3. Cordell G. A., Beecher C. W. Pezzuto J. M., J. Ethnopharmacol., 32, 117-133 (1991).
4. Schwartsmann G., Workman, P., Eur. J. Cancer, 29, 3-14 (1993).
5. Appolinary K., Charles N., Peter D. W., J. Ethnopharmacol., 70, 143-149 (2000).
6. Meng X. Z., Hu X. Q., Zhang R. M., You Y. T., J. Ningxia Univ. (Natural Science Edition), 15(2), 67-70 (1994).
7. Wu Y. K., Tian H. Y., Chang G. Q., Dan L., Li J. K., Anim. Toxicol., 13(1), 31-34 (1998).
8. Wu Y. K., Tian H. Y., Dan L., Yang Y. S., Li D. J., Chang G. Q., Li J. K. Chinese J. Vet. Sci., 19(1), 55-60 (1999).
9. Zhang J., Liu X. C., Chinese J. Vet. Med., (1), 46-48 (1994).
10. Cao G. R., Li S. J., Duan D. X., J. Northwest Agr. Univ., 17(3), 1-6 (1989).
11. Cao G. R., Li S. J., Duan D. X., Chinese J. Anim. Vet. Sci., 23, 135-140 (1992).
12. Wang K., Cao G. R., Duan D. X., Chinese J. Anim. Vet. Sci., 21, 80-86 (1999).
13. Zhang S. F., He B. X., Li X. M., J. Qinghai Anim. Vet., 91(1), 15-16 (1991).
14. Li S. Q., Cancer, Aberrance and Mutation, 2 (2), 53-59 (1990).
15. Li Y. K., "Chinese Medicine Experimental Methods in Pharmacology," Shanghai Science Technology Press, Shanghai, 1991, pp. 43-44.
16. Zhang J. T., "Modern Experimental Methods in Pharmacology," Beijing Medical University & Peking Union Medical College United Press, Beijing, 1998, pp. 75-76.
17. Chihara G., Hamuro J., Maeda Y. Y., Arai Y., Fukuoka F., Cancer Res., 30, 2776-2781 (1970).
18. Li Q. M., Yu Q., Min C. Y., World Chin. J. Digestol., 11(7), 997-1000 (2003).
19. Sasano H., Date F., Imatania A., Asaki S., Nagura H., Hum. Pathol., 24, 584-589 (1994).
20. Chen Q. Y., Wu Y. Q., He Y. S., Zhang C. H., Zhu Y. F., Med. J. Chin., 26(11), 835-836 (2001).
21. Wasseen X., Lane D., J. Cell Sci., 96(1), 121-123 (1990).
22. Chen Q. Y., Zhu Y. F., He Y. S., Wu Y. Q., Wang Z. Y., Cai Y., J. Tumor, 22(1), 68-69 (2002).
23. Hall P., Lane D., J. Pathol., 172(1), 1-5 (1994).
24. Rodrigus N., Rowan A., Smith M., Proc. Nat. Acad. Sci. U.S.A., 87(19), 7553-7554 (1990).